371 related articles for article (PubMed ID: 25929728)
1. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
Gomes ML; DeFreitas-Silva G; dos Reis PG; Melo MN; Frézard F; Demicheli C; Idemori YM
J Biol Inorg Chem; 2015 Jul; 20(5):771-9. PubMed ID: 25929728
[TBL] [Abstract][Full Text] [Related]
2. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
[TBL] [Abstract][Full Text] [Related]
3. Improved antileishmanial activity of Dppz through complexation with antimony(III) and bismuth(III): investigation of the role of the metal.
Lizarazo-Jaimes EH; Monte-Neto RL; Reis PG; Fernandes NG; Speziali NL; Melo MN; Frézard F; Demicheli C
Molecules; 2012 Oct; 17(11):12622-35. PubMed ID: 23099618
[TBL] [Abstract][Full Text] [Related]
4. Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.
Brochu C; Wang J; Roy G; Messier N; Wang XY; Saravia NG; Ouellette M
Antimicrob Agents Chemother; 2003 Oct; 47(10):3073-9. PubMed ID: 14506011
[TBL] [Abstract][Full Text] [Related]
5. Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.
Andrade JM; Baba EH; Machado-de-Avila RA; Chavez-Olortegui C; Demicheli CP; Frézard F; Monte-Neto RL; Murta SM
Antimicrob Agents Chemother; 2016 Aug; 60(8):4482-9. PubMed ID: 27161624
[TBL] [Abstract][Full Text] [Related]
6. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
[TBL] [Abstract][Full Text] [Related]
7. Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel α- and nor-α-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition.
Guimarães TT; Pinto Mdo C; Lanza JS; Melo MN; do Monte-Neto RL; de Melo IM; Diogo EB; Ferreira VF; Camara CA; Valença WO; de Oliveira RN; Frézard F; da Silva EN
Eur J Med Chem; 2013 May; 63():523-30. PubMed ID: 23535320
[TBL] [Abstract][Full Text] [Related]
8. Novel antimony(iii) hydroxamic acid complexes as potential anti-leishmanial agents.
Keogan DM; Oliveira SSC; Sangenito LS; Branquinha MH; Jagoo RD; Twamley B; Santos ALS; Griffith DM
Dalton Trans; 2018 May; 47(21):7245-7255. PubMed ID: 29757339
[TBL] [Abstract][Full Text] [Related]
9. Comparative stability, toxicity and anti-leishmanial activity of triphenyl antimony(v) and bismuth(v) α-hydroxy carboxylato complexes.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
Dalton Trans; 2018 Jan; 47(3):971-980. PubMed ID: 29260831
[TBL] [Abstract][Full Text] [Related]
10. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
[TBL] [Abstract][Full Text] [Related]
11. Comparative stability, cytotoxicity and anti-leishmanial activity of analogous organometallic Sb(V) and Bi(V) acetato complexes: Sb confirms potential while Bi fails the test.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
J Inorg Biochem; 2018 Dec; 189():151-162. PubMed ID: 30267965
[TBL] [Abstract][Full Text] [Related]
12. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
[TBL] [Abstract][Full Text] [Related]
13. Do bismuth complexes hold promise as antileishmanial drugs?
Ong YC; Kedzierski L; Andrews PC
Future Med Chem; 2018 Jul; 10(14):1721-1733. PubMed ID: 29961352
[TBL] [Abstract][Full Text] [Related]
14. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
Cantos G; Barbieri CL; Iacomini M; Gorin PA; Travassos LR
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):155-60. PubMed ID: 8424752
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)-sensitive and -resistant strains.
Islam A; do Prado BR; Dittz D; Rodrigues BL; Silva SMD; do Monte-Neto RL; Shabeer M; Frézard F; Demicheli C
Drug Dev Res; 2024 May; 85(3):e22194. PubMed ID: 38704828
[TBL] [Abstract][Full Text] [Related]
17. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
[TBL] [Abstract][Full Text] [Related]
18. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
[TBL] [Abstract][Full Text] [Related]
19. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis.
Walker J; Gongora R; Vasquez JJ; Drummelsmith J; Burchmore R; Roy G; Ouellette M; Gomez MA; Saravia NG
Mol Biochem Parasitol; 2012 Jun; 183(2):166-76. PubMed ID: 22449941
[TBL] [Abstract][Full Text] [Related]
20. ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.
Arcari T; Manzano JI; Gamarro F
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
